1.1 This guide is intended to be used in conjunction with the general requirements for the analysis of seized drugs (Practices E2326, E2327, E2329, and E2549; Guides E2548 and E2329). This guide provides guidance on the chemical analysis of items and samples related to suspected clandestine drug laboratories. It does not address scene attendance or scene processing. This document provides general guidance for the analysis of clandestine laboratory evidence and is not a substitute for detailed and validated laboratory policies and technical procedures.
1.2 This guide does not replace knowledge, skill, ability, experience, education, or training and should be used in conjunction with professional judgment.
ASTM E2882-12 Referenced Document
ASTM D6161 Standard Terminology Used for Crossflow Microfiltration, Ultrafiltration, Nanofiltration, and Reverse Osmosis Membrane Processes
ASTM E1605 Standard Terminology Relating to Lead in Buildings
ASTM E2326 Standard Practice for Education and Training of Seized-Drug Analysts*, 2024-04-20 Update
ASTM E2327 Standard Practice for Quality Assurance of Laboratories Performing Seized-Drug Analysis*, 2024-04-20 Update
ASTM E2329 Standard Practice for Identification of Seized Drugs
ASTM E2363 Standard Terminology Relating to Manufacturing of Pharmaceutical and Biopharmaceutical Products in the Pharmaceutical and Biopharmaceutical Industry
ASTM E2548 Standard Guide for Sampling Seized Drugs for Qualitative and Quantitative Analysis*, 2024-04-20 Update
ASTM E2549 Standard Practice for Validation of Seized-Drug Analytical Methods*, 2024-04-20 Update
ASTM F2725 Standard Guide for European Union's Registration, Evaluation, and Authorization of Chemicals (REACH) Supply Chain Information Exchange
ASTM E2882-12 history
2019ASTM E2882-19 Standard Guide for Analysis of Clandestine Drug Laboratory Evidence
2012ASTM E2882-12 Standard Guide for Analysis of Clandestine Drug Laboratory Evidence